CRISPR/Cas9-mediated gene knockout in human adipose stem/progenitor cells

References

• Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9945):766–781.
   PubMed Web of Science ®Google Scholar
• Ghaben AL, Scherer PE. Adipogenesis and metabolic health. Nat Rev Mol Cell Biol. 2019;20(4):242–258.
   PubMed Web of Science ®Google Scholar
• Kirkland JL, Tchkonia T, Pirtskhalava T, et al. Adipogenesis and aging: does aging make fat go MAD? Exp Gerontol. 2002;37(6):757–767.
   PubMed Web of Science ®Google Scholar
• Minamino T, Orimo M, Shimizu I, et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med. 2009;15(9):1082–1087.
   PubMed Web of Science ®Google Scholar
• Baker DJ, Childs BG, Durik M, et al. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature. 2016;530(7589):184–189.
   PubMed Web of Science ®Google Scholar
• Xu M, Palmer AK, Ding H, et al. Targeting senescent cells enhances adipogenesis and metabolic function in old age. eLife. 2015;4:e12997.
   PubMed Web of Science ®Google Scholar
• Berry DC, Jiang Y, Arpke RW, et al. Cellular aging contributes to failure of cold-induced beige adipocyte formation in old mice and humans. Cell Metab. 2017;25(1):166–181.
   PubMed Web of Science ®Google Scholar
• Guillermier C, Fazeli PK, Kim S, et al. Imaging mass spectrometry demonstrates age-related decline in human adipose plasticity. JCI Insight. 2017;2(5):e90349.
   PubMed Web of Science ®Google Scholar
• Mitterberger MC, Lechner S, Mattesich M, et al. Adipogenic differentiation is impaired in replicative senescent human subcutaneous adipose-derived stromal/progenitor cells. J Gerontol A Biol Sci Med Sci. 2014;69(1):13–24.
   PubMed Web of Science ®Google Scholar
• Ejaz A, Mitterberger MC, Lu Z, et al. Weight loss upregulates the small GTPase DIRAS3 in human white adipose progenitor cells, which negatively regulates adipogenesis and activates autophagy via Akt–mTOR inhibition. EBioMedicine. 2016;6:149–161.
   PubMed Web of Science ®Google Scholar
• Ejaz A, Mattesich M, Zwerschke W. Silencing of the small GTPase DIRAS3 induces cellular senescence in human white adipose stromal/progenitor cells. Aging (Albany NY). 2017;9(3):860–879.
   PubMedGoogle Scholar
• Mandl M, Wagner SA, Hatzmann FM, et al. Sprouty1 is a weight-loss target gene in human adipose stem/progenitor cells that is mandatory for the initiation of adipogenesis. Cell Death Dis. 2019;10(6):411.
   PubMedGoogle Scholar
• Mandl M, Wagner SA, Hatzmann FM, et al. Sprouty1 prevents cellular senescence maintaining proliferation and differentiation capacity of human adipose stem/progenitor cells. J Gerontol A Biol Sci Med Sci. 2020.
   PubMed Web of Science ®Google Scholar
• Mitterberger MC, Mattesich M, Zwerschke W. Bariatric surgery and diet-induced long-term caloric restriction protect subcutaneous adipose-derived stromal/progenitor cells and prolong their life span in formerly obese humans. Exp Gerontol. 2014;56:106–113.
   PubMed Web of Science ®Google Scholar
• Housden BE, Muhar M, Gemberling M, et al. Loss-of-function genetic tools for animal models: cross-species and cross-platform differences. Nat Rev Genet. 2017;18(1):24–40.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang Y, Gao F, et al. CRISPR/Cas9 genome-editing system in human stem cells: current status and future prospects. Mol Ther Nucleic Acids. 2017;9:230–241.
   PubMedGoogle Scholar
• Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346(6213):1258096.
   PubMed Web of Science ®Google Scholar
• Jinek M, Chylinski K, Fonfara I, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816–821.
   PubMed Web of Science ®Google Scholar
• Lino CA, Harper JC, Carney JP, et al. Delivering CRISPR: a review of the challenges and approaches. Drug Deliv. 2018;25(1):1234–1257.
   PubMed Web of Science ®Google Scholar
• Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods. 2014;11(8):783–784.
   PubMed Web of Science ®Google Scholar
• Mandl M, Depping R. ARNT is a potential direct HIF-1 target gene in human Hep3B hepatocellular carcinoma cells. Cancer Cell Int. 2017;17:77.
   PubMed Web of Science ®Google Scholar
• Mitterberger MC, Lechner S, Mattesich M, et al. DLK1(PREF1) is a negative regulator of adipogenesis in CD105(+)/CD90(+)/CD34(+)/CD31(-)/FABP4(-) adipose-derived stromal cells from subcutaneous abdominal fat pats of adult women. Stem Cell Res. 2012;9(1):35–48.
   PubMed Web of Science ®Google Scholar
• Hörl S, Ejaz A, Ernst S, et al. CD146 (MCAM) in human cs-DLK1(-)/cs-CD34(+) adipose stromal/progenitor cells. Stem Cell Res. 2017;22:1–12.
   PubMed Web of Science ®Google Scholar
• Shalem O, Sanjana NE, Hartenian E, et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science. 2014;343(6166):84–87.
   PubMed Web of Science ®Google Scholar
• Sentmanat MF, Peters ST, Florian CP, et al. Survey of validation strategies for CRISPR-Cas9 editing. Sci Rep. 2018;8(1):888.
   PubMedGoogle Scholar
• Brinkman EK, Chen T, Amendola M, et al. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 2014;42(22):e168.
   PubMed Web of Science ®Google Scholar
• Brinkman EK, van Steensel B. Rapid quantitative evaluation of CRISPR genome editing by TIDE and TIDER. Methods Mol Biol. 2019;1961:29–44.
   PubMedGoogle Scholar
• Huo W, Zhao G, Yin J, et al. Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells. J Cancer. 2017;8(1):57–64.
   PubMed Web of Science ®Google Scholar
• Yin Y, Zhong J, Li SW, et al. TRIM11, a direct target of miR-24-3p, promotes cell proliferation and inhibits apoptosis in colon cancer. Oncotarget. 2016;7(52):86755–86765.
   PubMedGoogle Scholar
• Knopp Y, Geis FK, Heckl D, et al. Transient retrovirus-based CRISPR/Cas9 all-in-one particles for efficient, targeted gene knockout. Mol Ther Nucleic Acids. 2018;13:256–274.
   PubMedGoogle Scholar
• Martufi M, Good RB, Rapiteanu R, et al. Single-step, high-efficiency CRISPR-Cas9 genome editing in primary human disease-derived fibroblasts. Crispr J. 2019;2:31–40.
   PubMedGoogle Scholar
• Hu W, Jiang C, Guan D, et al. Patient adipose stem cell-derived adipocytes reveal genetic variation that predicts antidiabetic drug response. Cell Stem Cell. 2019;24(2):299–308 e6.
   PubMed Web of Science ®Google Scholar
• Lessard S, Francioli L, Alfoldi J, et al. Human genetic variation alters CRISPR-Cas9 on- and off-targeting specificity at therapeutically implicated loci. Proc Natl Acad Sci U S A. 2017;114(52):E11257–E66.
   PubMed Web of Science ®Google Scholar
• Smits AH, Ziebell F, Joberty G, et al. Biological plasticity rescues target activity in CRISPR knock outs. Nat Methods. 2019;16(11):1087–1093.
   PubMed Web of Science ®Google Scholar
• Daer R, Hamna F, Barrett CM, et al. Site-directed targeting of transcriptional activation-associated proteins to repressed chromatin restores CRISPR activity. APL Bioeng. 2020;4(1):016102.
   PubMed Web of Science ®Google Scholar
• Zhang XH, Tee LY, Wang XG, et al. Off-target effects in CRISPR/Cas9-mediated genome engineering. Mol Ther Nucleic Acids. 2015;4:e264.
   PubMedGoogle Scholar
• Veres A, Gosis BS, Ding Q, et al. Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing. Cell Stem Cell. 2014;15(1):27–30.
   PubMed Web of Science ®Google Scholar
• Peretz L, Besser E, Hajbi R, et al. Combined shRNA over CRISPR/cas9 as a methodology to detect off-target effects and a potential compensatory mechanism. Sci Rep. 2018;8(1):93.
   PubMedGoogle Scholar
• Hart T, Tong AHY, Chan K, et al. Evaluation and design of genome-Wide CRISPR/SpCas9 knockout screens. G3. 2017;7(8):2719–2727.
   Web of Science ®Google Scholar